ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology

ACC CardiaCast

Content provided by American College of Cardiology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Cardiology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4y ago 11:27

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on June 01, 2023 04:07 (11M ago). Last successful fetch was on April 27, 2023 16:23 (12M ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs

96 episodes

#Fitness #Cardiology #Science #Medicine #American College Of Cardiology